Stewart & Patten Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,091
| Closed | -$214K | – | 91 |
|
|
2023
Q1 | $214K | Hold |
3,091
| – | – | 0.04% | 88 |
|
|
2022
Q4 | $222K | Hold |
3,091
| – | – | 0.04% | 84 |
|
|
2022
Q3 | $220K | Hold |
3,091
| – | – | 0.04% | 84 |
|
|
2022
Q2 | $238K | Hold |
3,091
| – | – | 0.04% | 76 |
|
|
2022
Q1 | $226K | Buy |
+3,091
| New | +$208K | 0.04% | 80 |
|
|
2021
Q3 | – | Sell |
-3,491
| Closed | -$233K | – | 91 |
|
|
2021
Q2 | $233K | Sell |
3,491
-100
| -3% | -$6.52K | 0.04% | 86 |
|
|
2021
Q1 | $227K | Hold |
3,591
| – | – | 0.04% | 82 |
|
|
2020
Q4 | $223K | Hold |
3,591
| – | – | 0.04% | 84 |
|
|
2020
Q3 | $217K | Hold |
3,591
| – | – | 0.04% | 84 |
|
|
2020
Q2 | $211K | Sell |
3,591
-600
| -14% | -$35.9K | 0.04% | 83 |
|
|
2020
Q1 | $234K | Sell |
4,191
-5,500
| -57% | -$336K | 0.05% | 77 |
|
|
2019
Q4 | $622K | Sell |
9,691
-10,094
| -51% | -$578K | 0.1% | 61 |
|
|
2019
Q3 | $1M | Buy |
19,785
+58
| +0.3% | +$2.73K | 0.18% | 47 |
|
|
2019
Q2 | $895K | Sell |
19,727
-148
| -0.7% | -$6.89K | 0.16% | 50 |
|
|
2019
Q1 | $948K | Sell |
19,875
-52
| -0.3% | -$2.59K | 0.17% | 48 |
|
|
2018
Q4 | $1.04M | Sell |
19,927
-649
| -3% | -$34.9K | 0.21% | 44 |
|
|
2018
Q3 | $1.28M | Sell |
20,576
-200
| -1% | -$11.9K | 0.23% | 42 |
|
|
2018
Q2 | $1.15M | Sell |
20,776
-599
| -3% | -$32.4K | 0.22% | 43 |
|
|
2018
Q1 | $1.35M | Buy |
21,375
+594
| +3% | +$38.2K | 0.26% | 40 |
|
|
2017
Q4 | $1.27M | Hold |
20,781
| – | – | 0.23% | 43 |
|
|
2017
Q3 | $1.32M | Sell |
20,781
-1,727
| -8% | -$101K | 0.24% | 39 |
|
|
2017
Q2 | $1.25M | Hold |
22,508
| – | – | 0.23% | 42 |
|
|
2017
Q1 | $1.22M | Sell |
22,508
-300
| -1% | -$16.5K | 0.23% | 42 |
|
|
2016
Q4 | $1.33M | Sell |
22,808
-360
| -2% | -$19.7K | 0.25% | 40 |
|
|
2016
Q3 | $1.25M | Sell |
23,168
-140
| -0.6% | -$8.99K | 0.24% | 40 |
|
|
2016
Q2 | $1.71M | Buy |
23,308
+300
| +1% | +$21.2K | 0.34% | 36 |
|
|
2016
Q1 | $1.47M | Hold |
23,008
| – | – | 0.29% | 39 |
|
|
2015
Q4 | $1.58M | Sell |
23,008
-1,100
| -5% | -$72.7K | 0.33% | 37 |
|
|
2015
Q3 | $1.43M | Sell |
24,108
-400
| -2% | -$25.4K | 0.32% | 37 |
|
|
2015
Q2 | $1.63M | Sell |
24,508
-100
| -0.4% | -$6.59K | 0.34% | 36 |
|
|
2015
Q1 | $1.59M | Sell |
24,608
-100
| -0.4% | -$6.26K | 0.33% | 36 |
|
|
2014
Q4 | $1.46M | Hold |
24,708
| – | – | 0.28% | 37 |
|
|
2014
Q3 | $1.26M | Sell |
24,708
-600
| -2% | -$30K | 0.26% | 38 |
|
|
2014
Q2 | $1.23M | Hold |
25,308
| – | – | 0.25% | 41 |
|
|
2014
Q1 | $1.31M | Hold |
25,308
| – | – | 0.27% | 42 |
|
|
2013
Q4 | $1.34M | Sell |
25,308
-800
| -3% | -$40.8K | 0.27% | 40 |
|
|
2013
Q3 | $1.21M | Sell |
26,108
-850
| -3% | -$37.3K | 0.26% | 40 |
|
|
2013
Q2 | $1.2M | Buy |
+26,958
| New | +$1.17M | 0.26% | 42 |
|
Other funds holding BMY
Stewart & Patten Company's BMY Position: Q2 2023 in Review
Stewart & Patten Company sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,091 shares — an estimated $214K sold.
Stewart & Patten Company first reported a position in BMY in Q2 2013 and held it in 38 quarters. The position peaked at $1.71M in Q2 2016. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Stewart & Patten Company reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- Stewart & Patten Company sold 3,091 Bristol-Myers Squibb shares in Q2 2023, an estimated $214K.
- Stewart & Patten Company first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 38 quarters.
- Stewart & Patten Company's Bristol-Myers Squibb position peaked at $1.71M in Q2 2016.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Stewart & Patten Company's 13F filing for Q2 2023, filed 19 Jul 2023.